NEW YORK, April 24-AnVil and Genomics Collaborative will be working together on a pilot project to apply new data analysis and visualization systems to microarray data, AnVil said in a statement today.

In the project, AnVil will apply its visualization and analysis tools to GCI's DNA microarray data.

The partnership is designed to help GCI identify gene expression patterns that could suggest new drug targets for inflammatory disease, especially rheumatoid arthritis.

AnVil, based in Burlington, Mass., is a privately held bioinformatics company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.